Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment
Clinical Rheumatology Mar 30, 2018
Yang L, et al. - In patients with rheumatoid arthritis (RA) with and without comorbid mild cognitive impairment (MCI), experts screened plasma to identify potential biomarkers useful in the differential diagnosis of comorbid MCI. They found that sonic hedgehog (SHH) and serum paraoxonase (TTR) could be candidate plasma biomarkers that could distinguish patients with RA and comorbid MCI from those without comorbid MCI.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries